526 related articles for article (PubMed ID: 33314471)
1. The long non-coding RNA landscape in triple-negative breast cancer.
Zhang W; Guan X; Tang J
Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
Wang Q; Gao S; Li H; Lv M; Lu C
J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
Mou E; Wang H
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
[TBL] [Abstract][Full Text] [Related]
7. Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer.
Singh DD; Lee HJ; Yadav DK
Cells; 2023 Feb; 12(4):. PubMed ID: 36831341
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB
J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151
[TBL] [Abstract][Full Text] [Related]
9. Progress of non-coding RNAs in triple-negative breast cancer.
Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel long non-coding RNAs in triple-negative breast cancer.
Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F
Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338
[TBL] [Abstract][Full Text] [Related]
12. Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis.
Nandagopal S; Misra S; Sankanagoudar S; Banerjee M; Sharma P; Pane SE; Guerriero G; Shukla KK
Asian Pac J Cancer Prev; 2023 Jan; 24(1):49-59. PubMed ID: 36708551
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications.
Rajagopal T; Talluri S; Venkatabalasubramanian S; Dunna NR
Biochem Soc Trans; 2020 Dec; 48(6):2791-2810. PubMed ID: 33258920
[TBL] [Abstract][Full Text] [Related]
14. Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring.
Zhou Y; Yue Y; Fan S; Jia Q; Ding X
Mol Biotechnol; 2021 Dec; 63(12):1093-1102. PubMed ID: 34245439
[TBL] [Abstract][Full Text] [Related]
15. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer.
Lv M; Xu P; Wu Y; Huang L; Li W; Lv S; Wu X; Zeng X; Shen R; Jia X; Yin Y; Gu Y; Yuan H; Xie H; Fu Z
Oncotarget; 2016 Mar; 7(11):13047-59. PubMed ID: 26910840
[TBL] [Abstract][Full Text] [Related]
16. The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs.
Brown JM; Wasson MD; Marcato P
Cells; 2020 Mar; 9(3):. PubMed ID: 32244924
[TBL] [Abstract][Full Text] [Related]
17. Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.
Chen C; Li Z; Yang Y; Xiang T; Song W; Liu S
Cancer Biol Ther; 2015; 16(6):856-65. PubMed ID: 25996380
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
[TBL] [Abstract][Full Text] [Related]
19. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer.
Yang Q; Fu Y; Wang J; Yang H; Zhang X
J Zhejiang Univ Sci B; 2023 Dec; 24(12):1123-1140. PubMed ID: 38057269
[TBL] [Abstract][Full Text] [Related]
20. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]